Commercialization building with large pharma contracts secured Further progress on next generation sequencing assays for DNA ...

Transwell assay showing increased invasion in SNB19 and U251 glioma cells transfected with FAM111B-overexpressing lentivirus, compared to controls. Magnification ×20 Study shows FAM111B overexpression ...

Collectively, the data presented here suggest that the PhasED-Seq-based MRD assay is accurate and reproducible, making it appropriate for use in the ...

Based on whole-genome sequencing (WGS), the investigational test detected circulating tumor (ct)DNA with a sensitivity and ...

Presentation to Highlight Genprex's Study of Reqorsa® Gene Therapy in Combination with Tecentriq® for the Treatment of Exten ...

Qiagen (NYSE:QGEN) announced a new commercial collaboration and joint marketing agreement with French company ID Solutions to ...

Researchers found that flight attendants show reduced DNA repair capacity and immune changes after air travel, which may help ...

A large trial shows that the vitamin may delay one biological mechanism linked to aging, but don’t rush out to buy ...

began by screening a large library of compounds for activators of wild-type POLγ, using a high-throughput in vitro DNA synthesis assay. Optimization of the top hit led to PZL-A, a small molecule ...

During a live event, Deborah Wong, MD, PhD, discussed the role of EBV and challenges in nasopharyngeal cancer diagnosis with ...

Qiagen has entered into a commercial collaboration with ID Solutions for digital polymerase chain reaction (dPCR) assays.